The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2000
DOI: 10.1097/00006254-200001000-00015
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of the Revised International Federation of Gynecology and Obstetrics Staging for Early Invasive Squamous Cervical Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2003
2003
2011
2011

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 0 publications
0
9
0
Order By: Relevance
“…Clinical staging of cervical cancers is accurate in only approximately 60% of cases, which is far less than surgical staging accuracy [2,3]. Lymph node metastasis is not a factor for FIGO staging; however, nodal metastases in gynecologic malignancies have an adverse impact on survival, especially in cases of paraaortic node involvement in cervical cancer [4,5]. Although nodal resection before radiation therapy results in a higher survival rate in patients with grossly enlarged pelvic and paraaortic lymph nodes [6,7], routine pretreatment surgical staging is not recommended.…”
Section: Webmentioning
confidence: 99%
“…Clinical staging of cervical cancers is accurate in only approximately 60% of cases, which is far less than surgical staging accuracy [2,3]. Lymph node metastasis is not a factor for FIGO staging; however, nodal metastases in gynecologic malignancies have an adverse impact on survival, especially in cases of paraaortic node involvement in cervical cancer [4,5]. Although nodal resection before radiation therapy results in a higher survival rate in patients with grossly enlarged pelvic and paraaortic lymph nodes [6,7], routine pretreatment surgical staging is not recommended.…”
Section: Webmentioning
confidence: 99%
“…Kasper et al 11 confirmed the report by Burghardt and Holzer 9 and Burghardt 10 that a tumour volume exceeding 500 mm 3 is an adverse prognostic indicator for cervical adenocarcinoma. They found no recurrence among patients with a tumour volume of 500 mm 3 or less.…”
Section: Discussionmentioning
confidence: 67%
“…They found no recurrence among patients with a tumour volume of 500 mm 3 or less. However, the maximum tumour volume of FIGO stages IA1 and IA2 tumours (if not exophytic or multifocal lesions) is 220.5 (3 Â 7 Â 10.5) mm 3 and 367.5 (5 Â 7 Â 10.5) mm 3 , respectively. Thus, we assume that the borderline tumour volume to define microinvasive cervical adenocarcinoma should be set at nearly half of that in Kasper et al's report 11 .…”
Section: Discussionmentioning
confidence: 95%
See 1 more Smart Citation
“…The prognostic factors identified in cervical cancer patients are tumor size, depth of stromal invasion, presence of lymphovascular tumor emboli, histologic type, and invasion of surgical margins [2,3]. Lymph node metastasis is also closely associated with poor prognosis and decreased survival rate [4]; moreover, this metastasis is an indicator for adjuvant radiotherapy [5].…”
Section: Introductionmentioning
confidence: 99%